共查询到17条相似文献,搜索用时 875 毫秒
1.
2.
利比里亚中国埃博拉诊疗中心因工作需要聘用了80名利方员工,进行了为期5天的岗前培训。内容包括医院整体情况介绍、埃博拉出血热相关知识、规章制度、工作流程、消毒隔离方法、个人防护用品(PPE)的穿脱训练、不良事件的处理流程、埃博拉患者心理干预等。培训方法多样化,采用理论授课、视频演示、操作示范、模拟练习、实地演练等,并将目标教学法和纠错法应用到整个培训过程中。培训结束后对所有聘用人员进行PPE穿脱考核,平均成绩93.8分,合格率97.5%。发放满意度调查问卷80份,收回80份,回收率100%,满意率达到95.8%。 相似文献
3.
4.
目的
探讨防护督查机制在埃博拉诊疗中心管理中的作用,探索防护督查机制对确保防护隔离制度执行、保障医务人员防护安全的作用和有效模式。方法 在制定八项防护隔离相关制度的基础上,建立防护督查制度、防护督查体系、工作模式以及评价措施。结果 分析2014年12月5日—2015年1月18日中国埃博拉诊疗中心防护督查工作情况,并进行前后期比较,发现通过建立完善的防护督查机制,能有效地纠正和减少防护隔离制度执行中的问题和失误,督促医务人员规范执行相关制度和流程。结论 防护督查机制是烈性传染病医院中进行防护质量控制的必要举措,对督促医务人员严格执行防护隔离相关制度、确保“零感染”具有切实有效的作用。 相似文献
5.
6.
7.
8.
埃博拉病毒可以引起一种人畜共患烈性传染病,即埃博拉出血热,此病于1976年始发于埃博拉河流域,并且于该区域严重流行,故而得名。人类一旦感染埃博拉病毒,死亡率可高达88%,从而引起医学界的广泛关注,世界卫生组织已将埃博拉病毒列为对人类危害最为严重的病毒之一。深入地了解埃博拉出血热及埃博拉病毒,及其致病机理,对于埃博拉出血热的预防和控制具有非常重要的意义。 相似文献
9.
10.
《微生物学免疫学进展》2017,(3)
埃博拉病毒(ebola virus,EBOV)是引起埃博拉病毒病(ebola hemorrhagic fever,EBHF)的病原体,属丝状病毒科。EBOV传染性强,致死率高;2014—2016年西非暴发埃博拉疫情共造成2.8万余人感染,1.1万余人死亡。早期、准确、灵敏的EBOV快速检测技术,可降低EBOV的传播风险。现从核酸检测及蛋白质检测技术两方面对EBOV快速检测的研究进展作一综述。 相似文献
11.
Md Ataul Islam 《Journal of biomolecular structure & dynamics》2013,31(15):4104-4119
AbstractEbola is a dangerous virus transmitted by animals and humans and to date there is no curable agent for such a deadly infectious disease. In this study, pharmacoinformatics-based methods were adopted to find effective novel chemical entities against Ebola virus. A well predictive and statistical robust pharmacophore model was developed from known Ebola virus inhibitors collected from the literature. The model explained the significance of each of hydrogen bond acceptor and donor, and two hydrophobic regions for activity. The National Cancer Institute and Asinex (Antiviral library) databases were screened using the final validated pharmacophore model. Initial hits were further screened with a set of criteria and finally eight molecules from both databases were proposed as promising anti Ebola agents. Further molecular docking and molecular dynamics studies were carried out and it was found that the proposed molecules possessed capability to interact with amino residues of Ebola protein as well as retaining equilibrium of protein-ligand systems. Finally, the binding energies were calculated using molecular mechanics Poisson–Boltzmann surface area approach and all proposed molecules showed strong binding affinity towards the Ebola protein receptor.Communicated by Ramaswamy H. Sarma 相似文献
12.
13.
In this paper the optimal control strategies of an SIR (susceptible–infected–recovered) epidemic model with time delay are introduced. In order to do this, we consider an optimally controlled SIR epidemic model with time delay where a control means treatment for infectious hosts. We use optimal control approach to minimize the probability that the infected individuals spread and to maximize the total number of susceptible and recovered individuals. We first derive the basic reproduction number and investigate the dynamical behavior of the controlled SIR epidemic model. We also show the existence of an optimal control for the control system and present numerical simulations on real data regarding the course of Ebola virus in Congo. Our results indicate that a small contact rate(probability of infection) is suitable for eradication of the disease (Ebola virus) and this is one way of optimal treatment strategies for infectious hosts. 相似文献
14.
于永利 《微生物学免疫学进展》2014,(6):1-7
2014年2月,死亡率极高的埃博拉病(EVD)开始在西部非洲的几内亚暴发流行,接下来,暴发流行出现在塞拉利昂、利比里亚、尼日利亚和塞内加尔另四个西部非洲的国家。现在,几内亚、利比里亚和塞拉利昂的疫情最重。迄今为止,已有4 784人患EVD,且人数仍在倍增,这次暴发流行已成为自40年前EVD被发现以来规模最大的一次,已形成了波及其他地区和国家的巨大危险。在此,综述2014年EVD暴发流行的起因,埃博拉病毒(EBOV)及其传播,EVD的诊断治疗,EBOV疫苗的研制以及EBOV感染的防控。 相似文献
15.
《Microbes and infection / Institut Pasteur》2015,17(2):109-117
Ebola virus infection can cause Ebola virus disease (EVD). Patients usually show severe symptoms, and the fatality rate can reach up to 90%. No licensed medicine is available. In this review, development of therapeutics for treatment of Ebola virus infection and EVD will be discussed. 相似文献
16.
Tao Zhang Min Zhai Jianbo Ji Jian Zhang Ye Tian Xinyong Liu 《Bioorganic & medicinal chemistry letters》2017,27(11):2364-2368
Ebola virus is one of the most threatening pathogens with the mortality rate as high as 90% in the world. There are no licensed therapeutic drugs or preventive vaccines for Ebola hemorrhagic fever up to date. Favipiravir, a novel antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection. In this review, we present an overview of recent progress on the treatment of Ebola virus disease with Favipiravir and describe its possible mechanism. Moreover, we give a brief summary of other related treatment strategies against Ebola. 相似文献
17.
埃博拉病等丝状病毒感染性疾病对人类的健康和生命造成了巨大的威胁,本文综述了有关丝状病毒的生物学特性、致病机制、免疫应答、治疗药物与疫苗研发工作的研究进展,为更好的认识丝状病毒感染规律和寻找埃博拉病等传染病的防治方法,提供一定的线索。 相似文献